CPT codes

53947 CPT codes with hospital pricing data in the network.

• CPT 44U — TBRF B GRP ANTB 4 PRTN IGG (85 hospitals, — samples)
• CPT 450T — INSJ AQUEOUS DRAIN DEV EACH (85 hospitals, — samples)
• CPT 450U — Oncology (multiple myeloma), liquid chromatography with tandem mass spectrometry (LC-MS/MS), monoclonal paraprotein sequencing analysis, serum, results reported as baseline presence or absence of detectable clonotypic peptides (85 hospitals, — samples)
• CPT 451U — Oncology (multiple myeloma), LC-MS/MS, peptide ion quantification, serum, results compared with baseline to determine monoclonal paraprotein abundance (85 hospitals, — samples)
• CPT 452U — Oncology (bladder), methylated PENK DNA detection by linear target enrichment-quantitative methylation-specific real-time PCR (LTE-qMSP), urine, reported as likelihood of bladder cancer (85 hospitals, — samples)
• CPT 453U — Oncology (colorectal cancer), cell-free DNA (cfDNA), methylation-based quantitative PCR assay (SEPTIN9, IKZF1, BCAT1, Septin9-2, VAV3, BCAN), plasma, reported as presence or absence of circulating tumor DNA (ctDNA) (85 hospitals, — samples)
• CPT 454U — Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping (85 hospitals, — samples)
• CPT 455U — Infectious agents (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, multiplex amplified probe technique, vaginal, endocervical, gynecological specimens, oropharyngeal swabs, rectal swabs, female or (85 hospitals, — samples)
• CPT 457U — Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 9 PFAS compounds by LC-MS/MS, plasma or serum, quantitative (85 hospitals, — samples)
• CPT 458U — Oncology (breast cancer), S100A8 and S100A9, by enzyme-linked immunosorbent assay (ELISA), tear fluid with age, algorithm reported as a risk score (85 hospitals, — samples)
• CPT 459U — β-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology (85 hospitals, — samples)
• CPT 45U — ONC BRST DUX CARC IS 12 GENE (85 hospitals, — samples)
• CPT 460U — Oncology, whole blood or buccal, DNA single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, with variant analysis and reported phenotypes (85 hospitals, — samples)
• CPT 461U — Oncology, pharmacogenomic analysis of single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, whole blood or buccal swab, with variant analysis, including impacted gene-drug interactions and reported phenotypes (85 hospitals, — samples)
• CPT 462U — Melatonin levels test, sleep study, 7 or 9 sample melatonin profile (cortisol optional), enzyme-linked immunosorbent assay (ELISA), saliva, screening/preliminary (85 hospitals, — samples)
• CPT 463U — Oncology (cervix), mRNA gene expression profiling of 14 biomarkers (E6 and E7 of the highest-risk human papillomavirus [HPV] types 16, 18, 31, 33, 45, 52, 58), by real-time nucleic acid sequence-based amplification (NASBA), exo- or endocervical epithelial (85 hospitals, — samples)
• CPT 464T — VISUAL EP TEST FOR GLAUCOMA (85 hospitals, — samples)
• CPT 464U — Oncology (colorectal) screening, quantitative real-time target and signal amplification, methylated DNA markers, including LASS4, LRRC4 and PPP2R5C, a reference marker ZDHHC1, and a protein marker (fecal hemoglobin), utilizing stool, algorithm reported as (85 hospitals, — samples)
• CPT 465T — Injection Of Medication Into Space Above Choroid Membrane Of Eye (7 hospitals, — samples)
• CPT 465U — Oncology (urothelial carcinoma), DNA, quantitative methylation-specific PCR of 2 genes (ONECUT2, VIM), algorithmic analysis reported as positive or negative (85 hospitals, — samples)
• CPT 466U — Cardiology (coronary artery disease [CAD]), DNA, genome-wide association studies (564856 single-nucleotide polymorphisms [SNPs], targeted variant genotyping), patient lifestyle and clinical data, buccal swab, algorithm reported as polygenic risk to acquir (85 hospitals, — samples)
• CPT 467U — Oncology (bladder), DNA, next-generation sequencing (NGS) of 60 genes and whole genome aneuploidy, urine, algorithms reported as minimal residual disease (MRD) status positive or negative and quantitative disease burden (85 hospitals, — samples)
• CPT 468U — Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a-5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis (85 hospitals, — samples)
• CPT 469U — Rare diseases (constitutional/heritable disorders), whole genome sequence analysis for chromosomal abnormalities, copy number variants, duplications/deletions, inversions, unbalanced translocations, regions of homozygosity (ROH), inheritance pattern that (85 hospitals, — samples)
• CPT 46U — FLT3 GENE ITD VARIANTS QUAN (85 hospitals, — samples)
• CPT 470T — Oct Scan Of Skin Lesion With Interpretation And Report, First Lesion (9 hospitals, — samples)
• CPT 470U — Oncology (oropharyngeal), detection of minimal residual disease by next-generation sequencing (NGS) based quantitative evaluation of 8 DNA targets, cell-free HPV 16 and 18 DNA from plasma (85 hospitals, — samples)
• CPT 471T — Oct Scan Of Skin Lesion With Interpretation And Report, Each Additional Lesion (9 hospitals, — samples)
• CPT 471U — Oncology (colorectal cancer), qualitative real-time PCR of 35 variants of KRAS and NRAS genes (exons 2, 3, 4), formalin-fixed paraffin-embedded (FFPE), predictive, identification of detected mutations (85 hospitals, — samples)
• CPT 472T — PRGRMG IO RTA ELTRD RA (85 hospitals, — samples)
• CPT 472U — Carbonic anhydrase VI (CA VI), parotid specific/secretory protein (PSP) and salivary protein (SP1) IgG, IgM, and IgA antibodies, enzyme-linked immunosorbent assay (ELISA), semiqualitative, blood, reported as predictive evidence of early Sjögren's syndrome (85 hospitals, — samples)
• CPT 473T — REPRGRMG IO RTA ELTRD RA (85 hospitals, — samples)
• CPT 473U — Oncology (solid tumor), next-generation sequencing (NGS) of DNA from formalin-fixed paraffin-embedded (FFPE) tissue with comparative sequence analysis from a matched normal specimen (blood or saliva), 648 genes, interrogation for sequence variants, insert (85 hospitals, — samples)
• CPT 474 — ANESTH SURGERY OF RIB (91 hospitals, — samples)
• CPT 474T — INSJ AQUEOUS DRG DEV IO RSVR (84 hospitals, — samples)
• CPT 474U — Hereditary pan-cancer (eg, hereditary sarcomas, hereditary endocrine tumors, hereditary neuroendocrine tumors, hereditary cutaneous melanoma), genomic sequence analysis panel of 88 genes with 20 duplications/deletions using next-generation sequencing (NGS (85 hospitals, — samples)
• CPT 475T — Recording Of Fetal Magnetic Heart Signal With Technical Analysis And Interpretation Of Report (7 hospitals, — samples)
• CPT 475U — Hereditary prostate cancer-related disorders, genomic sequence analysis panel using next-generation sequencing (NGS), Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), and array comparative genomic hybridization (CGH), evaluation (85 hospitals, — samples)
• CPT 476T — Recording Of Fetal Magnetic Heart Signal With Electronic Signal Transfer Of Data And Storage (7 hospitals, — samples)
• CPT 476U — Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia), whole blood, buccal swab, and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant anal (85 hospitals, — samples)
• CPT 477T — Recording Of Fetal Magnetic Heart Signal With Signal Extraction, Technical Analysis, And Result (7 hospitals, — samples)
• CPT 477U — Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia), whole blood, buccal swab, and pharmacogenomic genotyping of 14 genes and CYP2D6 copy number variant anal (85 hospitals, — samples)
• CPT 478T — Recording Of Fetal Magnetic Heart Signal With Review And Interpretation Of Report (7 hospitals, — samples)
• CPT 478U — Oncology (non-small cell lung cancer), DNA and RNA, digital PCR analysis of 9 genes (EGFR, KRAS, BRAF, ALK, ROS1, RET, NTRK 1/2/3, ERBB2, and MET) in formalin-fixed paraffin-embedded (FFPE) tissue, interrogation for single-nucleotide variants, insertions/ (85 hospitals, — samples)
• CPT 479T — FXJL ABL LSR 1ST 100 SQ CM (85 hospitals, — samples)
• CPT 479U — Tau, phosphorylated, pTau217 (85 hospitals, — samples)
• CPT 47U — ONC PRST8 MRNA 17 GENE ALG (85 hospitals, — samples)
• CPT 480T — FXJL ABL LSR EA ADDL 100SQCM (85 hospitals, — samples)
• CPT 481T — NJX AUTOL WBC CONCENTRATE (85 hospitals, — samples)
• CPT 481U — IDH1 (isocitrate dehydrogenase 1 [NADP+]), IDH2 (isocitrate dehydrogenase 2 [NADP+]), and TERT (telomerase reverse transcriptase) promoter (eg, central nervous system [CNS] tumors), next-generation sequencing (single-nucleotide variants [SNV], deletions, (85 hospitals, — samples)